February 3, 2024

The crisis of adolescent mental health: creating new solutions for teens and families

Adolescent mental health concerns have reached a new scale in recent years, with serious implications for teens, their families, and society. A survey from the CDC found that in the 10 years leading up to the pandemic, feelings of persistent sadness and hopelessness increased by about 40% among young people.1

There is an increased urgency to understand the drivers behind this crisis and develop accessible and scalable solutions to reach those in need. Addressing these complex issues requires a full-societal approach. Big Health, the leading provider of digital therapeutics and evidence-based programs for mental health, convened a digital roundtable to discuss the adolescent mental health crisis and the need to expand access to care.

Our speakers discussed:
– The drivers and impact of the youth mental health crisis
– The power of technology to increase access to care
– How to create a diverse benefits offering for the whole family
– Emerging evidence-based care modalities, including a solution from Big Health

Submit the form to watch the replay

1. Centers for Disease Control and Prevention. (2021). Youth Risk Behavior Survey Data Summary & Trends Report: 2011-2021.

Watch the replay

During the COVID-19 public health emergency, Sleepio and Daylight are being made available as treatments for insomnia disorder and generalized anxiety disorder (GAD), respectively, without a prescription. Sleepio and Daylight have not been cleared by the U.S. Food and Drug Administration (FDA) for the treatment of insomnia disorder and GAD, respectively.

1. Qaseem, A., Kansagara, D., Forciea, M. A., Cooke, M., & Denberg, T. D. (2016). Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Annals of Internal Medicine, 165(2), 125-133.2. Riemann, D., Baglioni, C., Bassetti, C., Bjorvatn, B., Dolenc Groselj, L., Ellis, J. G., … & Spiegelhalder, K. (2017). European guideline for the diagnosis and treatment of insomnia. Journal of Sleep Research, 26(6), 675-700.3. Wilson, S., Anderson, K., Baldwin, D., Dijk, D. J., Espie, A., Espie, C., … & Sharpley, A. (2019). British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: an update. Journal of Psychopharmacology, 33(8), 923-947.4. King’s Technology Evaluation Centre. (2017, November 9). Overview: Health app: SLEEPIO for adults with poor Sleep: Advice. NICE. https://www.nice.org.uk/advice/mib129.5. Espie, C. A., Kyle, S. D., Williams, C., Ong, J. C., Douglas, N. J., Hames, P., & Brown, J. S. (2012). A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia disorder delivered via an automated media-rich web application. Sleep, 35(6), 769-781.6. Carl, J. R., Miller, C. B., Henry, A. L., Davis, M. L., Stott, R., Smits, J. A., … & Espie, C. A. (2020). Efficacy of digital cognitive behavioral therapy for moderate‐to‐severe symptoms of generalized anxiety disorder: A randomized controlled trial. Depression and Anxiety, 37(12), 1168-1178.

DOC-3046 Effective 11/2023